{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:06:01Z","timestamp":1780682761638,"version":"3.54.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-037938"],"award-info":[{"award-number":["INV-037938"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Foreign Affairs, Trade and Development, Government of Canada"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>The COVID-19 pandemic led to significantly disrupted tuberculosis case detection and management. Additionally, overlapping symptoms, radiological findings and risk factors make differentiating tuberculosis and COVID-19 disease difficult. We conducted a prospective multicentre diagnostic accuracy study to determine sensitivity, specificity and operational characteristics of the Truenat MTB Ultima\/COVID-19 assay, using a combined sputum plus nasopharyngeal swab specimen, in a single multiplex molecular assay. Participants were consenting adults with presumptive tuberculosis enrolled via convenience sampling from Uganda, Peru, South Africa, and India between August 2022 and December 2023. A microbiological reference standard of sputum GeneXpert MTB\/RIF Ultra and culture was used for tuberculosis, whereas national RT-PCR was used for COVID-19. Wilson\u2019s score method was used to determine the sensitivity and specificity. Of 1,928 participants enrolled, median age was 38 years (IQR 28\u201350), 359\/1928 (18.6%) previously had TB, and 287\/1928 (14.9%) were HIV-positive. Overall prevalence of tuberculosis was 24.8% [95% CI 22.9-26.8%]. Prevalence of COVID-19 was 3.8% [3.1-4.8%] overall, and 4.7% [3.1-7.0%] in those with confirmed tuberculosis. Overall sensitivity of Truenat MTB Ultima\/COVID-19 for tuberculosis was 79.8% [95% CI 76.0-83.2%]. When comparing paired samples, Truenat MTB Ultima\/COVID-19 had a 9.5% [6.5-13.1%] decreased sensitivity against sputum TB culture, compared to GeneXpert Ultra; (82.8% [78.9-86.1%] vs 92.4% [89.4-94.5%]). Overall specificity of Truenat MTB Ultima\/COVID-19 for tuberculosis was 98.9% [98.2-99.3%]. For COVID-19 detection, sensitivity of Truenat MTB Ultima\/COVID-19 was 64.4% [52.9-74.4%], with specificity of 99.2% [98.7-99.5%]. Although optimal diagnostic performance was not demonstrated, the potential and need for rapid development of tests that integrate tuberculosis diagnosis with detection of other relevant respiratory infections is highlighted. The study was registered on ClinicalTrials.gov (NCT05405296).<\/jats:p>","DOI":"10.1371\/journal.pgph.0005859","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:49:33Z","timestamp":1780681773000},"page":"e0005859","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy study of the multiplex Truenat MTB Ultima\/COVID-19 assay for simultaneous detection of Tuberculosis and SARS-CoV2 (COVID-19)"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-8060","authenticated-orcid":true,"given":"Hafsah","family":"Tootla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sz\u00e9kely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sserubiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widaad","family":"Zemanay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mala","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-9087","authenticated-orcid":true,"given":"Cesar","family":"Ugarte-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Ruhwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-7305","authenticated-orcid":true,"given":"Manju","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Zamudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-110X","authenticated-orcid":true,"given":"Willy","family":"Ssengooba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-0059","authenticated-orcid":true,"given":"Adam","family":"Penn-Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COMBO study team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"pgph.0005859.ref001","volume-title":"Global Tuberculosis Report 2025","author":"World Health Organization","year":"2025"},{"key":"pgph.0005859.ref002","author":"World Health Organisation","year":"2024"},{"key":"pgph.0005859.ref003","volume-title":"The End TB Strategy. Report No.: WHO\/HTM\/TB\/2015.9","author":"World Health Organisation","year":"2015"},{"key":"pgph.0005859.ref004","volume-title":"The Global Plan to End TB 2023-2030","author":"The Stop TB Partnership","year":"2022"},{"issue":"6","key":"pgph.0005859.ref005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","article-title":"The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions","volume":"10","author":"K Dheda","year":"2022","journal-title":"Lancet Respir Med"},{"key":"pgph.0005859.ref006","volume-title":"Global tuberculosis report 2021","author":"World Health Organization","year":"2021"},{"issue":"6","key":"pgph.0005859.ref007","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5588\/ijtld.21.0148","article-title":"The impact of COVID-19 on TB: a review of the data","volume":"25","author":"CF McQuaid","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"pgph.0005859.ref008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.5588\/ijtld.22.0006","article-title":"The COVID-19 and TB syndemic: the way forward","volume":"26","author":"A Trajman","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"pgph.0005859.ref009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.pulmoe.2020.05.002","article-title":"Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts","volume":"26","author":"I Motta","year":"2020","journal-title":"Pulmonology"},{"issue":"5","key":"pgph.0005859.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012136","article-title":"Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerations","volume":"18","author":"Q Wang","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pgph.0005859.ref011","doi-asserted-by":"crossref","first-page":"1620210","DOI":"10.3389\/fpubh.2025.1620210","article-title":"Performance evaluation of the Molbio diagnostics Truenat MTB Ultima\/COVID-19 multiplex assay for TB and COVID-19 case detection among people with symptoms suggestive of tuberculosis-a study protocol for clinical trials","volume":"13","author":"M Purohit","year":"2025","journal-title":"Front Public Health"},{"key":"pgph.0005859.ref012","volume-title":"WHO consolidated guidelines on tuberculosis. Module 3: diagnosis","author":"World Health Organisation","year":"2025"},{"issue":"6","key":"pgph.0005859.ref013","article-title":"Xpert MTB\/RIF and Xpert MTB\/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults","volume":"6","author":"DJ Horne","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pgph.0005859.ref014","article-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"2014","author":"KR Steingart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"pgph.0005859.ref015","article-title":"Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study","volume":"4","author":"EL-H MacLean","year":"2023","journal-title":"Lancet Microbe"},{"issue":"4","key":"pgph.0005859.ref016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5588\/ijtldopen.24.0561","article-title":"Accuracy of Truenat\u2122 MTB Plus for the diagnosis of pulmonary TB","volume":"2","author":"MCM Melo","year":"2025","journal-title":"IJTLD Open"},{"issue":"12","key":"pgph.0005859.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261084","article-title":"Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia","volume":"16","author":"A Meaza","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"pgph.0005859.ref018","doi-asserted-by":"crossref","first-page":"2100526","DOI":"10.1183\/13993003.00526-2021","article-title":"A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays","volume":"58","author":"A Penn-Nicholson","year":"2021","journal-title":"Eur Respir J"},{"issue":"7","key":"pgph.0005859.ref019","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cmi.2025.04.013","article-title":"Diagnostic accuracy of Truenat MTB Ultima on sputum for pulmonary tuberculosis diagnosis in an HIV-endemic setting","volume":"31","author":"SM Abdulgader","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"pgph.0005859.ref020","doi-asserted-by":"crossref","first-page":"105991","DOI":"10.1016\/j.ebiom.2025.105991","article-title":"Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluation","volume":"121","author":"A Steadman","year":"2025","journal-title":"eBioMedicine"},{"key":"pgph.0005859.ref021","unstructured":"Mbuli C, Bosco TFJ, Nsamenang R, Nestor B, Nguimfack G, Mbuh N, et al. Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon."},{"key":"pgph.0005859.ref022","article-title":"Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB\/RIF Ultra testing: a prospective diagnostic accuracy study","author":"M De Vos","year":"2026","journal-title":"The Lancet Microbe"},{"issue":"5","key":"pgph.0005859.ref023","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2016321","article-title":"Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing","volume":"383","author":"Y-P Tu","year":"2020","journal-title":"N Engl J Med"},{"key":"pgph.0005859.ref024","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab039","article-title":"Performance of unobserved self-collected nasal swabs for detection of SARS-CoV-2 by RT-PCR utilizing a remote specimen collection strategy","volume":"8","author":"RM Kagan","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"pgph.0005859.ref025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jinf.2021.09.012","article-title":"Self-collected mid-nasal swabs and saliva specimens, compared with nasopharyngeal swabs, for SARS-CoV-2 detection in mild COVID-19 patients","volume":"83","author":"A Alemany","year":"2021","journal-title":"J Infect"},{"key":"pgph.0005859.ref026","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2021\/50628.15680","article-title":"Performance of Chip Based Real Time RT- PCR (TrueNat) and Conventional Real Time RT-PCR for Detection of SARS-CoV-2. JCDR","author":"A Sahoo","year":"2021"},{"key":"pgph.0005859.ref027","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/ijmr.IJMR_2363_20","article-title":"Performance evaluation of Truenat\u2122 Beta CoV & Truenat\u2122 SARS-CoV-2 point-of-care assays for coronavirus disease 2019","volume":"153","author":"SG Basawarajappa","year":"2021","journal-title":"Indian J Med Res"},{"key":"pgph.0005859.ref028","doi-asserted-by":"crossref","DOI":"10.12688\/verixiv.2002.1","article-title":"Evaluation of sensitivity of the Truenat MTB Ultima\/COVID-19 assay to detect SARS-CoV-2 in frozen nasopharyngeal samples. Gates Foundation","author":"N Chandwani","year":"2025"},{"issue":"6552","key":"pgph.0005859.ref029","article-title":"Estimating epidemiologic dynamics from cross-sectional viral load distributions","volume":"373","author":"JA Hay","year":"2021","journal-title":"Science"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:49:41Z","timestamp":1780681781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005859"}},"subtitle":[],"editor":[{"given":"Ankur","family":"Gupta-Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005859","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}